Compare · OST vs TMO
OST vs TMO
Side-by-side comparison of Ostin Technology Group Co. Ltd. (OST) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- OST operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO carries a market cap of $175.70B.
- Over the past year, OST is down 98.9% and TMO is up 14.9% - TMO leads by 113.8 points.
- TMO has hit the wire 17 times in the past 4 weeks while OST has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for OST).
- Company
- Ostin Technology Group Co. Ltd.
- Thermo Fisher Scientific Inc
- Price
- $1.72+0.29%
- $469.56-0.67%
- Market cap
- -
- $175.70B
- 1M return
- +0.00%
- -1.03%
- 1Y return
- -98.89%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 17
- Recent ratings
- 0
- 25
Ostin Technology Group Co. Ltd.
Ostin Technology Group Co., Ltd. designs, develops, and manufactures thin-film transistor liquid crystal display (TFT-LCD) modules and polarizers in China. The company offers TFT-LCD solutions for drive IC, TCON board, and power supply applications; back light systems and special modules; LC display modules, touch panel modules, and smart display terminals; and polarizers used in the TFT-LCD display modules. It offers display modules to markets, such as consumer electronics, including AIOs, monitors, laptop computers, and tablets; automotive displays, including dashboard, and navigation and multimedia systems; and outdoor LCD displays, which are used to display multimedia graphics, such as company advertisements, promotions, scoreboards, and traffic signs. The company sells its products directly to customers, as well as to customers' designated system integrators. Ostin Technology Group Co., Ltd. was founded in 2010 and is based in Nanjing, China with manufacturing facilities in China.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest OST
- SEC Form 3 filed by new insider Cui Rongguo
- SEC Form 3 filed by new insider Yin Xiao Hong
- SEC Form 3 filed by new insider Mein John Carl
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- SEC Form 20-F filed by Ostin Technology Group Co. Ltd.
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- Mass Production Ignition Ceremony for Colorless Transparent Polyimide Thin Film Production Line of SAEM For Ostin Group
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)